
Biotech projects on medicines in development in Spain 2025, by therapeutic area
As of February 2025, cancer was the therapeutic area with the highest share of biotech projects on medicines in development in Spain. By origin, around 73 percent were investigated by multinational subsidiaries, while 33 percent corresponded to national companies. Moreover, biotechnology projects on drugs for the central nervous system made up about 26 percent of the biotech pipeline on medications under development in Spanish companies as of that date.